Position in LFCR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$50,220
-$60,210 QoQ
Shares Held
13,500
0.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GABELLI FUNDS LLC holds $36,352,371 across 10 Drug Manufacturers - Specialty & Generic names. LFCR ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
332,900 | $10,026,948 | |
| 2 | PRGO |
PERRIGO Co plc
|
893,359 | $9,594,675 | |
| 3 | ZTS |
Zoetis Inc.
|
60,450 | $7,145,794 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
134,250 | $3,212,602 | |
| 5 | VTRS |
Viatris Inc
|
213,200 | $2,880,332 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
24,000 | $1,820,400 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
23,000 | $1,188,870 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
56,000 | $302,400 |
All Filings in LFCR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,220 | 13,500 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $110,430 | 13,500 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $99,360 | 13,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $109,620 | 13,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $95,040 | 13,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $100,305 | 13,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $88,740 | 18,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $99,009 | 19,300 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $100,890 | 19,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $113,277 | 18,300 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $125,330 | 16,600 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $160,522 | 16,600 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $64,260 | 17,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $115,344 | 17,800 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $155,575 | 17,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $174,475 | 17,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $156,330 | 13,500 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $149,850 | 13,500 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $225,890 | 24,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $438,750 | 39,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $307,400 | 29,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $249,550 | 23,000 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||